Septic Shock
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
25 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 40 trials with date data
Clinical Trials (40)
Total enrollment: 13,073 patients across 40 trials
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Albumin Replacement Therapy in Septic Shock
Stress Hydrocortisone In Pediatric Septic Shock
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure
Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
The Cooling And Surviving Septic Shock Study (CASS)
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Esmolol Effects on Heart and Inflammation in Septic Shock
Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock
Effects of the V1a Agonist FE 202158 in Patients With Septic Shock
Fluid Resuscitation in Early Septic Shock
Adrecizumab-LPS Study
Adrecizumab Phase 1 Trial
Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study)
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock
Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
Blood Purification for the Treatment of Pathogen Associated Shock
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
CytOSorb TreatMent Of Critically Ill PatientS Registry
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
Adjuvant Therapy With CytoSorb in Refractory Septic Shock
Whether a Minimal Volume Could Predict Fluid Responsiveness Using Thermodilution by PAC in Septic Shock Patients
Cytokine Adsorption in Severe, Refractory Septic Shock
Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy
Life After Pediatric Sepsis Evaluation
The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic Shock
Continuos Terlipressin Infusion in Septic Shock
Examination of ADMA Serum Level and DDAH II
Near Infrared Spectroscopy (St02)
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.